CLINICAL_TRIALS
trial_result
· 2018-10-16
Clinical Trial Update: Study of the Combination of Apatinib and POF [Phase 2]
Summary
Phase 2 clinical trial update on the combination of Apatinib and POF for gastric adenocarcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujian Cancer Hospital | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: UNKNOWN